These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 20920139)
1. The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease. Corte TJ; Gatzoulis MA; Parfitt L; Harries C; Wells AU; Wort SJ Respirology; 2010 Nov; 15(8):1226-32. PubMed ID: 20920139 [TBL] [Abstract][Full Text] [Related]
2. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use? Chapman TH; Wilde M; Sheth A; Madden BP Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283 [TBL] [Abstract][Full Text] [Related]
3. [Selective vasodilation in the lung. Sildenafil improves physical capacity and prognosis]. MMW Fortschr Med; 2007 May; 149(22):45. PubMed ID: 18069228 [No Abstract] [Full Text] [Related]
4. Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: case report and review of the literature. Mercurio V; Carlomagno G; Fazio S Heart Lung; 2012; 41(5):512-7. PubMed ID: 22054725 [TBL] [Abstract][Full Text] [Related]
5. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease? Madden BP; Sheth A; Wilde M; Ong YE Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899 [TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension. Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension. Dumitrescu D; Seck C; Möhle L; Erdmann E; Rosenkranz S Int J Cardiol; 2012 Jan; 154(2):205-6. PubMed ID: 22104986 [No Abstract] [Full Text] [Related]
9. [Primary arterial pulmonary hypertension and sildenafil: a case report from Dakar]. Bouldouyre M; Dia D; Ba FK; Diop IB; Debonne JM Dakar Med; 2006; 51(2):78-80. PubMed ID: 17632981 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension. Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071 [TBL] [Abstract][Full Text] [Related]
11. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil. Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406 [TBL] [Abstract][Full Text] [Related]
12. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension. Gough MS; White RJ Liver Transpl; 2009 Jan; 15(1):30-6. PubMed ID: 19109844 [TBL] [Abstract][Full Text] [Related]
13. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease. Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015 [TBL] [Abstract][Full Text] [Related]
14. [Sildenafil treatment of unilateral pulmonary edema and pulmonary hypertension in pulmonary artery agenesis]. Rodríguez-Gómez F; Martín I; Sánchez A; Pujol E Rev Esp Cardiol; 2006 Dec; 59(12):1347-9. PubMed ID: 17194435 [No Abstract] [Full Text] [Related]
15. Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis-related lung disease. Montgomery GS; Sagel SD; Taylor AL; Abman SH Pediatr Pulmonol; 2006 Apr; 41(4):383-5. PubMed ID: 16479610 [TBL] [Abstract][Full Text] [Related]
16. Sildenafil in older patients with secondary pulmonary hypertension. Minotti GC; Corsonello A; Incalzi RA J Am Geriatr Soc; 2007 Oct; 55(10):1681-2. PubMed ID: 17908072 [No Abstract] [Full Text] [Related]
17. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease. Madden BP; Allenby M; Loke TK; Sheth A Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495 [TBL] [Abstract][Full Text] [Related]
18. Sildenafil in the management of the failing Fontan circulation. Reinhardt Z; Uzun O; Bhole V; Ofoe V; Wilson D; Onuzo O; Wright JG; Stumper O Cardiol Young; 2010 Oct; 20(5):522-5. PubMed ID: 20519058 [TBL] [Abstract][Full Text] [Related]
19. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Sheth A; Park JE; Ong YE; Ho TB; Madden BP Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248 [TBL] [Abstract][Full Text] [Related]
20. Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors. Zimmermann GS; von Wulffen W; Huppmann P; Meis T; Ihle F; Geiseler J; Leuchte HH; Tufman A; Behr J; Neurohr C Respirology; 2014 Jul; 19(5):700-6. PubMed ID: 24697923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]